Moolec Science (NASDAQ:MLEC – Get Free Report) is one of 665 publicly-traded companies in the “Holding & other investment offices” industry, but how does it contrast to its competitors? We will compare Moolec Science to similar businesses based on the strength of its analyst recommendations, valuation, risk, earnings, dividends, institutional ownership and profitability.
Profitability
This table compares Moolec Science and its competitors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Moolec Science | -129.97% | -93.88% | -33.37% |
Moolec Science Competitors | -17.70% | -42.87% | -0.63% |
Valuation and Earnings
This table compares Moolec Science and its competitors top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Moolec Science | $5.63 million | -$7.31 million | -4.23 |
Moolec Science Competitors | $995.69 million | $80.90 million | 72.67 |
Insider & Institutional Ownership
0.1% of Moolec Science shares are held by institutional investors. Comparatively, 54.4% of shares of all “Holding & other investment offices” companies are held by institutional investors. 19.9% of Moolec Science shares are held by insiders. Comparatively, 26.1% of shares of all “Holding & other investment offices” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations for Moolec Science and its competitors, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Moolec Science | 0 | 0 | 1 | 0 | 3.00 |
Moolec Science Competitors | 128 | 728 | 960 | 19 | 2.47 |
Moolec Science presently has a consensus target price of $6.00, indicating a potential upside of 609.14%. As a group, “Holding & other investment offices” companies have a potential upside of 53.54%. Given Moolec Science’s stronger consensus rating and higher possible upside, research analysts clearly believe Moolec Science is more favorable than its competitors.
Volatility and Risk
Moolec Science has a beta of -0.54, indicating that its share price is 154% less volatile than the S&P 500. Comparatively, Moolec Science’s competitors have a beta of 0.03, indicating that their average share price is 97% less volatile than the S&P 500.
Summary
Moolec Science competitors beat Moolec Science on 10 of the 13 factors compared.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.